The Hong Kong International Biotechnology Convention (BIOHK2023) came to a successful conclusion in the golden fall. The forum revived its former bustling scene after the epidemic and witnessed the vigorous development of science and technology in Hong Kong.
Dr. Vince Gao, Chief Scientist of Govita, was invited to attend the event and shared our latest research result on “Ultra-Early Cardiovascular Risk Screening and Management” with every guest present.